221 related articles for article (PubMed ID: 27681103)
1. Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.
Zhong S; Han W; Hou C; Liu J; Wu L; Liu M; Liang Z; Lin H; Zhou L; Liu S; Tang L
AAPS J; 2017 Jan; 19(1):203-214. PubMed ID: 27681103
[TBL] [Abstract][Full Text] [Related]
2. STAT5A and STAT5B have opposite correlations with drug response gene expression.
Lamba V; Jia B; Liang F
Biochem Biophys Res Commun; 2016 Oct; 479(2):117-124. PubMed ID: 27264955
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the UDP-glucuronosyltransferase transcriptome in human tissues.
Zhou L; Montalvo AD; Collins JM; Wang D
Pharmacol Res Perspect; 2023 Dec; 11(6):e01154. PubMed ID: 37983911
[TBL] [Abstract][Full Text] [Related]
4. In vitro interaction of a novel neutrophil growth factor with human liver microsomal cytochromes P450 and the contribution of UDP-glucuronosyltransferases to its metabolism.
Siller M; Anzenbacher P; Anzenbacherová E; Doležal K; Strnad M
Xenobiotica; 2011 Nov; 41(11):934-44. PubMed ID: 21745145
[TBL] [Abstract][Full Text] [Related]
5. Variation in the expression of cytochrome P450-related miRNAs and transcriptional factors in human livers: Correlation with cytochrome P450 gene phenotypes.
Zhang HF; Zhu LL; Yang XB; Gao N; Fang Y; Wen Q; Qiao HL
Toxicol Appl Pharmacol; 2021 Feb; 412():115389. PubMed ID: 33385404
[TBL] [Abstract][Full Text] [Related]
6. Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver.
Liu W; Ramírez J; Gamazon ER; Mirkov S; Chen P; Wu K; Sun C; Cox NJ; Cook E; Das S; Ratain MJ
Hum Mol Genet; 2014 Oct; 23(20):5558-69. PubMed ID: 24879639
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of UDP-glucuronosyltransferases in CCl
Xu L; Zheng R; Xie P; Guo Q; Ji H; Li T
Chem Biol Interact; 2020 Jul; 325():109115. PubMed ID: 32380060
[TBL] [Abstract][Full Text] [Related]
8. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism.
Fisher MB; Paine MF; Strelevitz TJ; Wrighton SA
Drug Metab Rev; 2001; 33(3-4):273-97. PubMed ID: 11768770
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
10. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of human UDP-glucuronosyltransferase genes.
Hu DG; Meech R; McKinnon RA; Mackenzie PI
Drug Metab Rev; 2014 Nov; 46(4):421-58. PubMed ID: 25336387
[TBL] [Abstract][Full Text] [Related]
12. Tissue-, sex- and development-specific transcription profiles of eight UDP-glucuronosyltransferase genes in zebrafish (Danio rerio) and their regulation by activator of aryl hydrocarbon receptor.
Christen V; Fent K
Aquat Toxicol; 2014 May; 150():93-102. PubMed ID: 24667232
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.
Cao L; Greenblatt DJ; Kwara A
Drug Metab Dispos; 2017 Sep; 45(9):1035-1043. PubMed ID: 28663285
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in hepatic expression and activity of drug metabolizing enzymes in male wild-type and breast cancer resistance protein knockout mice.
Zheng H; Wang L; Zeng S; Chen J; Wang H; Yu J; Gong X; Jiang H; Yang X; Qi X; Wang Y; Lu L; Hu M; Zhu L; Liu Z
Biopharm Drug Dispos; 2018 Jul; 39(7):344-353. PubMed ID: 30016542
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of drug-metabolizing enzymes in human hepatocarcinoma FLC-4 cells cultured on micro-space cell culture plates.
Kobayashi K; Yoshida A; Ejiri Y; Takagi S; Mimura H; Hosoda M; Matsuura T; Chiba K
Drug Metab Pharmacokinet; 2012; 27(5):478-85. PubMed ID: 22447115
[TBL] [Abstract][Full Text] [Related]
16. Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors.
Bock KW
Biochem Pharmacol; 2012 Oct; 84(8):1000-6. PubMed ID: 22820246
[TBL] [Abstract][Full Text] [Related]
17. Identification and hepatic expression profiles of cytochrome P450 1-4 isozymes in common minke whales (Balaenoptera acutorostrata).
Niimi S; Kim EY; Iwata H; Watanabe MX; Yasunaga G; Fujise Y; Tanabe S
Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):667-81. PubMed ID: 17526421
[TBL] [Abstract][Full Text] [Related]
18. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure.
Zhang M; Rottschäfer V; C M de Lange E
Drug Metab Rev; 2024 Feb; 56(1):1-30. PubMed ID: 38126313
[TBL] [Abstract][Full Text] [Related]
19. Effects of diammonium glycyrrhizinate on hepatic and intestinal UDP-Glucuronosyltransferases in rats: Implication in herb-drug interactions.
Li FY; Xie H; Weng L; Wang H; Cao LJ; Hao HP; Wang GJ
Chin J Nat Med; 2016 Jul; 14(7):534-40. PubMed ID: 27507204
[TBL] [Abstract][Full Text] [Related]
20. The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.
Liu Y; She M; Wu Z; Dai R
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):386-93. PubMed ID: 20939765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
